Risk of unwarranted pregnancies with morning after pill conscience clauses
January 30, 2013 in Medications
Conscience clauses, which allow pharmacists to opt out of providing the "morning after pill" without a prescription, risk unwanted pregnancies and undermine the principle of universal healthcare in the NHS, say pharmacists in the Journal of Medical Ethics.
These clauses should either be banned or enhanced so that pharmacists and patients know exactly where they stand, rather than the current "fudge", which serves nobody well, the authors conclude.
Emergency hormonal contraception without a prescription became available from UK pharmacies in 2001 and the Republic of Ireland in 2011.
Built-in conscience clauses allow pharmacists to opt-out of provision on moral or religious grounds, providing they refer patients to other providers willing to prescribe the product.
The morning after pill has been the subject of a string of legal challenges, and those who believe it is wrong to provide it, often do so on the grounds that it could harm the developing embryo, say the authors.
But this ignores the principle of patient autonomy - "a core tenet of contemporary healthcare" - and arguably begs the question of why those with strong objections to carrying out a routine aspect of their profession should nevertheless opt for a job in which this is required, argue the authors.
"What pharmacists in such cases are demanding is the power of veto over the liberty of others, and over the implementation of public policy," they write.
Under current regulations, pharmacists who hold religious and moral objections to providing the morning after pill must refer women to another appropriate source of supply. This opt out allows them to convince themselves that referral does not constitute supply, say the authors, but what of their professional duty to the patient?
What happens if no such alternative supply is available within the 72 hour time limit in which emergency hormonal contraception works - a particular issue for women in rural areas, for example - ask the authors?
There is nothing in the current legislation, or indeed professional guidance, which addresses that, they point out.
"Although the important distinction between objection and obstruction seems to be recognised by the regulatory bodies, they lack the impetus to follow their assertions through to their logical conclusion," they write.
To be morally defensible and legally feasible, rules and regulations governing the supply of the morning after pill must be universally applicable, the authors contend.
"The current status quo is not satisfactory to either conscientious objectors or to those who must regulate them," they write.
"Either [the professional regulators] must compel all pharmacists to dispense emergency hormonal contraception to all patients meeting the clinical criteria who request it….or the pharmacist must refuse both to supply [it] and to refer the patient to an alternative supplier," they argue.
More information: The fox and the grapes: an Anglo-Irish perspective on conscientious objection to the supply of emergency hormonal contraception without prescription, Online First, doi:10.1136/medethics-2012-100975
Journal reference:
Journal of Medical Ethics
Provided by
British Medical Journal
-
Welsh girls to get morning-after pill for free
Apr 01, 2011 |
not rated yet |
0
-
Study: Health undervalued in reproductive rights debate
Apr 01, 2009 |
not rated yet |
0
-
Fed judge considers if pharmacies must sell Plan B
Feb 02, 2012 |
not rated yet |
0
-
Buffalo-area pharmacists say no to tobacco sales in pharmacies
Oct 30, 2012 |
not rated yet |
0
-
Wide-reaching report finds strong support for nurse and pharmacist prescribing
May 10, 2011 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013
-
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013
-
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
- More from Physics Forums - Medical Sciences
More news stories
Feds fight morning-after pill age ruling in NY
(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...
Medications
19 hours ago |
not rated yet |
0
Merck ends development of Parkinson's disease drug
(AP)—Merck & Co. says it is ending development of an experimental Parkinson's disease drug because the drug wasn't working.
Medications
May 23, 2013 |
1 / 5 (1) |
0
J&J expects 10-plus new drug applications by 2017
(AP)—Johnson & Johnson is developing what could eventually be game-changing treatments for depression and pain, and it's aiming to apply for approval of more than 10 new medicines by 2017, executives said Thursday during ...
Medications
May 23, 2013 |
5 / 5 (1) |
0
Experts favor US approval of Merck sleeping pill (Update)
An independent panel of experts on Wednesday recommended US approval of a new Merck sleeping pill called suvorexant, but expressed concerns over the highest dosage and risks of drowsy daytime driving.
Medications
May 22, 2013 |
not rated yet |
0
Glaxo, US partnering to develop new antibiotics
GlaxoSmithKline PLC says it's starting an unusual collaboration with the U.S. government to develop several antibiotics for both bioterrorism threats and bacterial infections resistant to current medicines.
Medications
May 22, 2013 |
not rated yet |
0
First drug to improve heart failure mortality in over a decade
Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...
Seniors more likely to crash when driving with pet, study finds
(HealthDay)—Animals make great companions for senior citizens, but elderly people who always drive with a pet in the car are far more likely to crash than those who never drive with a pet, researchers have ...
Heart failure accelerates male 'menopause'
Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...
New immune system discovered
(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.
Death highest in heart failure patients admitted in January, on Friday, and overnight
Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...
Brain can be trained in compassion, study shows
Until now, little was scientifically known about the human potential to cultivate compassion—the emotional state of caring for people who are suffering in a way that motivates altruistic behavior.